Mach MRFF Rart 2.1 - Component B

Tenecteplase versus Alteplase for Stroke Thrombolysis Evaluation Trial in the Ambulance (Mobile Stroke Unit - TASTE-A): Protocol for a prospective randomised, open-label, blinded endpoint, phase II superiority trial of tenecteplase versus alteplase for ischaemic stroke patients presenting within 4.5 hours of symptom onset to the mobile stroke unit

A Bivard, H Zhao, S Coote, B Campbell, L Churilov, N Yassi, B Yan, M Valente, A Sharobeam, A Balabanski, A Dos Santos, F Ng, F Langenberg, M Stephenson, K Smith, S Bernard, V Thijs, G Cloud, P Choi, H Ma

2022-04-29

Introduction Mobile stroke units (MSUs) equipped with a CT scanner are increasingly being used to assess and treat stroke patients..